Welcome to our dedicated page for Columbia Financ SEC filings (Ticker: CLBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Columbia Financial, Inc. (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank. Through these filings, investors can review detailed disclosures on the company’s financial condition, results of operations, capital management, and significant corporate events.
Columbia Financial, Inc. uses current reports on Form 8-K to announce material events. Recent 8-K filings have covered quarterly earnings releases, including financial results for periods ended March 31, June 30, and September 30, as well as the year ended December 31. These filings typically reference press releases furnished as exhibits that discuss net interest income, interest expense on deposits and borrowings, provision for credit losses, non-interest income and expense, net interest margin, and overall net income or loss.
Other 8-K filings describe corporate actions and governance matters. For example, the company has filed 8-Ks regarding authorization of a stock repurchase program to acquire up to 1,800,000 shares of common stock, including details on regulatory non-objection, permitted repurchase methods, and program terms. Additional 8-Ks disclose executive officer changes, such as the planned end date of employment for a Senior Executive Vice President and Chief Operating Officer, and the availability of investor presentations outlining operating and growth strategies.
Annual reports on Form 10-K and quarterly reports on Form 10-Q, when accessed alongside these current reports, provide comprehensive information on Columbia Financial, Inc.’s loan portfolio composition, deposit base, funding sources, balance sheet repositioning transactions, asset quality metrics, and risk factors. These filings also describe the company’s structure as a Delaware corporation and majority-owned subsidiary of Columbia Bank, MHC, and its role as the holding company for Columbia Bank, a federally chartered savings bank headquartered in Fair Lawn, New Jersey.
Stock Titan’s platform enhances these filings by delivering real-time updates from the SEC’s EDGAR system and AI-powered summaries that highlight key points from lengthy documents. Users can quickly identify important information in 10-K and 10-Q reports, track material events reported on Form 8-K, and review disclosures related to capital actions such as stock repurchase programs. Insider transaction reports on Form 4, where available, can also be monitored to see reported purchases and sales by directors and executive officers.
By combining Columbia Financial, Inc.’s official SEC filings with AI-generated insights, this page helps readers understand how the company describes its performance, strategy, and risk profile in its own regulatory disclosures.
Columbia Financial, Inc. director Noel R. Holland reported a small acquisition of phantom stock tied to company shares. On January 23, 2026, a trustee for the bank’s rabbi trust purchased 10.7115 phantom stock units at $15.91 each under the Columbia Bank Stock Based Deferral Plan, bringing Holland’s beneficial interest in that plan to 10,011.7382 units, which will be settled in stock at distribution.
Holland also reports holding 33,519 shares of common stock directly, 46,280 shares indirectly through a SEP-IRA, and 3,207 shares through a stock award granted under the 2019 Equity Incentive Plan that vests on March 11, 2026. In addition, Holland holds 83,294 stock options with a $15.60 exercise price, fully vested and exercisable until July 23, 2029.
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported an update to his equity holdings. On January 9, 2026, 41.7294 phantom stock units of Columbia Financial common stock were purchased on a non-discretionary basis by the trustee of the bank’s rabbi trust for the Columbia Bank Stock Based Deferral Plan at $15.30 per unit, increasing his indirect beneficial interest in that deferral plan to 8,182.7185 units.
He also reports existing holdings of common stock both directly and through vehicles such as a 401(k), ESOP, SERP, SIM, and multiple stock award programs, along with stock options granted under the 2019 Equity Incentive Plan, some of which are fully vested and others that vest in scheduled annual installments.
Columbia Financial, Inc. President & CEO Thomas J. Kemly, who is also a director, reported an indirect acquisition of common stock-linked units on January 9, 2026. He acquired 116.8059 shares of Common Stock at $15.30 per share, held through a Stock-Based Deferral Plan maintained in a bank rabbi trust. According to the footnote, these phantom stock units were purchased on a non-discretionary basis by the plan trustee and will be settled in shares of stock upon distribution to him.
Following this transaction, Kemly indirectly held 66,605.8569 shares through the Stock-Based Deferral Plan, along with additional direct and indirect holdings in Columbia Financial common stock and multiple tranches of stock options granted under the company’s 2019 Equity Incentive Plan.
Columbia Financial, Inc. reported an insider ownership update for its SEVP & Chief Risk Officer. On 12/26/2025, a non-discretionary purchase of 39.6067 shares of common stock at $16.12 per share was made through the Columbia Bank Stock Based Deferral Plan, increasing the officer’s balance in that plan to 8,140.9891 shares. The officer also holds 60,769 common shares directly and additional indirect holdings through a 401(k), ESOP, SERP, SIM, and performance-based stock awards under the 2019 Equity Incentive Plan. The filing further lists stock options to buy 188,235, 12,030, 8,850 and 20,310 common shares at exercise prices between $15.6 and $16.49, with vesting schedules beginning between 2024 and 2026 and expirations between 2029 and 2035.
Columbia Financial, Inc. director reported a routine acquisition of 153.0193 shares of phantom stock on 12/26/2025 at $16.12 per share through the Columbia Bank Stock Based Deferral Plan. These stock unit interests will be settled in actual shares upon distribution.
After this transaction, the director reports beneficial ownership of 9,993.0194 shares through the stock-based deferral plan, 39,934 shares directly, 44,447 shares via an IRA, 6,704 shares via a Roth IRA, and 3,207 shares through a stock award that vests on March 11, 2026 under the 2019 Equity Incentive Plan.
The filing also lists 62,474 stock options with an exercise price of $15.60 per share, granted under the 2019 Equity Incentive Plan, which are fully vested and exercisable and expire on 07/23/2029.
Columbia Financial, Inc.'s President and CEO, who is also a director, reported acquiring 104.3884 phantom common stock units through the Columbia Bank Stock Based Deferral Plan on December 12, 2025 at $17.12 per unit. This transaction increased the reporting person's stock-based deferral plan balance to 66,378.1868 units, which will be settled in shares of stock upon distribution.
The report also outlines the reporting person's broader ownership in Columbia Financial common stock, including 233,808 shares held directly and additional indirect holdings through retirement and incentive plans and by a spouse. Under the 2019 Equity Incentive Plan, the reporting person holds stock options covering 656,471 shares at a $15.6 exercise price that are fully vested and exercisable, plus further option grants over 37,894, 37,168 and 94,749 shares at exercise prices of $15.94, $16.49 and $16.23, vesting in three approximately equal annual installments beginning in 2024, 2025 and 2026.
Columbia Financial, Inc. reported that its SEVP & Chief Risk Officer acquired 37.2932 phantom stock units representing common stock on 12/12/2025 at $17.12 through the Columbia Bank Stock Based Deferral Plan. The units were purchased on a non-discretionary basis by the trustee of the bank’s rabbi trust and will be settled in shares of stock upon distribution to the reporting person.
After this transaction, the officer indirectly holds 8,101.3824 stock-based deferral plan units, in addition to 60,769 common shares held directly and further indirect holdings through a 401(k), ESOP, SERP, SIM and several stock award programs. The report also lists stock options under the 2019 Equity Incentive Plan, including 188,235 fully vested options at $15.6 expiring on 07/23/2029, plus additional grants of 12,030, 8,850 and 20,310 options at exercise prices of $15.94, $16.49 and $16.23, vesting in installments through 2035.
Columbia Financial, Inc. reported that its SEVP & Head of Consumer Banking acquired 19.5456 phantom stock units tied to common stock on 12/12/2025 through the Columbia Bank Stock Based Deferral Plan at $17.12 per unit. After this trustee-directed purchase in the plan’s rabbi trust, the executive beneficially owns 13,522.6081 shares indirectly via the deferral plan, 64,281 shares directly, and additional indirect holdings through the ESOP, SERP, SIM, and several performance-based stock awards. The filing also lists stock options to buy 155,294 shares at an exercise price of $15.60 expiring on 07/23/2029, plus option grants for 12,632, 9,292 and 21,289 shares at exercise prices between $15.94 and $16.49 expiring between 2033 and 2035.
Columbia Financial, Inc. (CLBK) reported an insider equity transaction by a senior executive serving as SEVP & Chief Risk Officer. On 11/14/2025, the executive acquired 42.3944 shares of common stock at $15.06 per share through a stock-based deferral plan, increasing the balance in the stock-based deferral plan to 8,023.7569 shares held indirectly.
In addition, the executive reports 60,769 common shares held directly and indirect holdings of 17,130 shares in a 401(k), 7,620 shares in an ESOP, 7,051 shares in a SERP, 4,214 shares in a SIM, and performance-linked stock awards of 13,781, 12,068, and 11,723 shares under various award programs. The filing also lists stock options to buy 188,235 shares at $15.60 expiring on 07/23/2029 (fully vested), plus additional options on 12,030, 8,850, and 20,310 shares with exercise prices between $15.94 and $16.49 that vest in three approximately equal annual installments starting in 2024, 2025, and 2026, respectively.
Columbia Financial, Inc. (CLBK) reported an insider equity transaction by its SEVP & Head of Consumer Banking on a Form 4. On 11/14/2025, the reporting person acquired 22.2191 shares of Columbia Financial common stock at a price of $15.06 per share through a stock-based deferral plan, described as phantom stock purchased on a non-discretionary basis by the trustee of the bank's rabbi trust. After this transaction, the reporting person beneficially owned 13,481.9241 shares through the stock-based deferral plan, along with additional direct and indirect holdings through an ESOP, SERP, SIM, and multiple stock award programs under the 2019 Equity Incentive Plan.
The filing also lists several outstanding stock options granted under the 2019 Equity Incentive Plan with exercise prices between $15.6 and $16.49, expiration dates ranging from 07/23/2029 to 03/03/2035, and vesting schedules tied to time-based and performance-based criteria.